APROVEL 300 MG COM REV CT BL AL PLAS OPC X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1832604500021 -
GGREM
576720090089517 -
Código de barras
7891058010782
O que a fonte publica
- Detentor do registro
- SANOFI MEDLEY FARMACÊUTICA LTDA.
- Princípios ativos
- IRBESARTANA
- Embalagem
- 300 MG COM REV CT BL AL PLAS OPC X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- C9C - ANTAGONISTAS DA ANGIOTENSINA II PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "APROVEL 300 MG COM REV CT BL AL PLAS OPC X 30",
"holder": "SANOFI MEDLEY FARMACÊUTICA LTDA.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891058010782"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "576720090089517",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "10.588.595/0010-92",
"priceRegime": "Regulado",
"productName": "APROVEL",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "300 MG COM REV CT BL AL PLAS OPC X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "165.67",
"icms-12": "188.26",
"icms-17": "199.60",
"icms-18": "202.04",
"icms-19": "204.53",
"icms-20": "207.09",
"icms-21": "209.71",
"icms-22": "212.40",
"icms-23": "215.16",
"icms-17.5": "200.81",
"icms-19.5": "205.80",
"icms-20.5": "208.39",
"icms-22.5": "213.77",
"icms-12-alc": "186.00",
"icms-17-alc": "197.21",
"icms-18-alc": "199.61",
"icms-19-alc": "202.08",
"icms-20-alc": "204.60",
"icms-21-alc": "207.19",
"icms-22-alc": "209.85",
"icms-23-alc": "212.57",
"withoutTaxes": "163.68",
"icms-17.5-alc": "198.40",
"icms-19.5-alc": "203.33",
"icms-20.5-alc": "205.89",
"icms-22.5-alc": "211.20"
},
"pisCofinsList": "Positiva",
"substanceText": "IRBESARTANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "228.36",
"icms-12": "259.50",
"icms-17": "275.13",
"icms-18": "278.49",
"icms-19": "281.92",
"icms-20": "285.45",
"icms-21": "289.06",
"icms-22": "292.77",
"icms-23": "296.58",
"icms-17.5": "276.80",
"icms-19.5": "283.67",
"icms-20.5": "287.24",
"icms-22.5": "294.66",
"icms-12-alc": "257.13",
"icms-17-alc": "272.63",
"icms-18-alc": "275.95",
"icms-19-alc": "279.36",
"icms-20-alc": "282.85",
"icms-21-alc": "286.43",
"icms-22-alc": "290.11",
"icms-23-alc": "293.87",
"withoutTaxes": "226.28",
"icms-17.5-alc": "274.28",
"icms-19.5-alc": "281.09",
"icms-20.5-alc": "284.63",
"icms-22.5-alc": "291.97"
},
"invalidBarcodes": [],
"activeSubstances": [
"IRBESARTANA"
],
"therapeuticClass": "C9C - ANTAGONISTAS DA ANGIOTENSINA II PUROS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1832604500021",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C9C",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:576720090089517"